Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment

Kenta Nakamura, Tomonori Yaguchi, Gaku Ohmura, Asuka Kobayashi, Naoshi Kawamura, Takashi Iwata, Yukiko Kiniwa, Ryuhei Okuyama, Yutaka Kawakami

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To improve current cancer immunotherapies, strategies to modulate various immunosuppressive cells including myeloid derived suppressor cells (MDSC) which were shown to be negative factors in immune-checkpoint blockade therapy, need to be developed. In the present study, we evaluated the role of the local renin-angiotensin system (RAS) in the tumor immune-microenvironment using murine models bearing tumor cell lines in which RAS was not involved in their proliferation and angiogenetic ability. Giving angiotensin II receptor blockers (ARB) to C57BL/6 mice bearing murine colon cancer cell line MC38 resulted in significant enhancement of tumor antigen gp70 specific T cells. ARB administration did not change the numbers of CD11b+ myeloid cells in tumors, but significantly reduced their T-cell inhibitory ability along with decreased production of various immunosuppressive factors including interleukin (IL)-6, IL-10, vascular endothelial growth factor (VEGF), and arginase by CD11b+ cells in tumors. ARB also decreased expression of immunosuppressive factors such as chemokine ligand 12 and nitric oxide synthase 2 in cancer-associated fibroblasts (CAF). Last, combination of ARB and anti-programmed death-ligand 1 (PD-L1) antibodies resulted in significant augmentation of anti-tumor effects in a CD8+ T cell-dependent way. These results showed that RAS is involved in the generation of an immunosuppressive tumor microenvironment caused by myeloid cells and fibroblasts, other than the previously shown proliferative and angiogenetic properties of cancer cells and macrophages, and that ARB can transform the immunosuppressive properties of MDSC and CAF and could be used in combination with PD-1/PD-L1 immune-checkpoint blockade therapy.

Original languageEnglish
Pages (from-to)54-64
Number of pages11
JournalCancer Science
Volume109
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Tumor Microenvironment
Angiotensin Receptor Antagonists
Immunosuppressive Agents
Renin-Angiotensin System
Immunosuppression
Myeloid Cells
Neoplasms
Ligands
T-Lymphocytes
Arginase
Immunologic Factors
Neoplasm Antigens
Tumor Cell Line
Inbred C57BL Mouse
Chemokines
Nitric Oxide Synthase
Interleukin-10
Immunotherapy
Colonic Neoplasms
Vascular Endothelial Growth Factor A

Keywords

  • angiotensin receptor antagonist
  • cancer-associated fibroblast
  • myeloid cell
  • programmed cell death 1 receptor
  • renin-angiotensin system

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment. / Nakamura, Kenta; Yaguchi, Tomonori; Ohmura, Gaku; Kobayashi, Asuka; Kawamura, Naoshi; Iwata, Takashi; Kiniwa, Yukiko; Okuyama, Ryuhei; Kawakami, Yutaka.

In: Cancer Science, Vol. 109, No. 1, 01.01.2018, p. 54-64.

Research output: Contribution to journalArticle

Nakamura, K, Yaguchi, T, Ohmura, G, Kobayashi, A, Kawamura, N, Iwata, T, Kiniwa, Y, Okuyama, R & Kawakami, Y 2018, 'Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment', Cancer Science, vol. 109, no. 1, pp. 54-64. https://doi.org/10.1111/cas.13423
Nakamura, Kenta ; Yaguchi, Tomonori ; Ohmura, Gaku ; Kobayashi, Asuka ; Kawamura, Naoshi ; Iwata, Takashi ; Kiniwa, Yukiko ; Okuyama, Ryuhei ; Kawakami, Yutaka. / Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment. In: Cancer Science. 2018 ; Vol. 109, No. 1. pp. 54-64.
@article{6e6a6641361c4a3286a4b864bad365bd,
title = "Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment",
abstract = "To improve current cancer immunotherapies, strategies to modulate various immunosuppressive cells including myeloid derived suppressor cells (MDSC) which were shown to be negative factors in immune-checkpoint blockade therapy, need to be developed. In the present study, we evaluated the role of the local renin-angiotensin system (RAS) in the tumor immune-microenvironment using murine models bearing tumor cell lines in which RAS was not involved in their proliferation and angiogenetic ability. Giving angiotensin II receptor blockers (ARB) to C57BL/6 mice bearing murine colon cancer cell line MC38 resulted in significant enhancement of tumor antigen gp70 specific T cells. ARB administration did not change the numbers of CD11b+ myeloid cells in tumors, but significantly reduced their T-cell inhibitory ability along with decreased production of various immunosuppressive factors including interleukin (IL)-6, IL-10, vascular endothelial growth factor (VEGF), and arginase by CD11b+ cells in tumors. ARB also decreased expression of immunosuppressive factors such as chemokine ligand 12 and nitric oxide synthase 2 in cancer-associated fibroblasts (CAF). Last, combination of ARB and anti-programmed death-ligand 1 (PD-L1) antibodies resulted in significant augmentation of anti-tumor effects in a CD8+ T cell-dependent way. These results showed that RAS is involved in the generation of an immunosuppressive tumor microenvironment caused by myeloid cells and fibroblasts, other than the previously shown proliferative and angiogenetic properties of cancer cells and macrophages, and that ARB can transform the immunosuppressive properties of MDSC and CAF and could be used in combination with PD-1/PD-L1 immune-checkpoint blockade therapy.",
keywords = "angiotensin receptor antagonist, cancer-associated fibroblast, myeloid cell, programmed cell death 1 receptor, renin-angiotensin system",
author = "Kenta Nakamura and Tomonori Yaguchi and Gaku Ohmura and Asuka Kobayashi and Naoshi Kawamura and Takashi Iwata and Yukiko Kiniwa and Ryuhei Okuyama and Yutaka Kawakami",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/cas.13423",
language = "English",
volume = "109",
pages = "54--64",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment

AU - Nakamura, Kenta

AU - Yaguchi, Tomonori

AU - Ohmura, Gaku

AU - Kobayashi, Asuka

AU - Kawamura, Naoshi

AU - Iwata, Takashi

AU - Kiniwa, Yukiko

AU - Okuyama, Ryuhei

AU - Kawakami, Yutaka

PY - 2018/1/1

Y1 - 2018/1/1

N2 - To improve current cancer immunotherapies, strategies to modulate various immunosuppressive cells including myeloid derived suppressor cells (MDSC) which were shown to be negative factors in immune-checkpoint blockade therapy, need to be developed. In the present study, we evaluated the role of the local renin-angiotensin system (RAS) in the tumor immune-microenvironment using murine models bearing tumor cell lines in which RAS was not involved in their proliferation and angiogenetic ability. Giving angiotensin II receptor blockers (ARB) to C57BL/6 mice bearing murine colon cancer cell line MC38 resulted in significant enhancement of tumor antigen gp70 specific T cells. ARB administration did not change the numbers of CD11b+ myeloid cells in tumors, but significantly reduced their T-cell inhibitory ability along with decreased production of various immunosuppressive factors including interleukin (IL)-6, IL-10, vascular endothelial growth factor (VEGF), and arginase by CD11b+ cells in tumors. ARB also decreased expression of immunosuppressive factors such as chemokine ligand 12 and nitric oxide synthase 2 in cancer-associated fibroblasts (CAF). Last, combination of ARB and anti-programmed death-ligand 1 (PD-L1) antibodies resulted in significant augmentation of anti-tumor effects in a CD8+ T cell-dependent way. These results showed that RAS is involved in the generation of an immunosuppressive tumor microenvironment caused by myeloid cells and fibroblasts, other than the previously shown proliferative and angiogenetic properties of cancer cells and macrophages, and that ARB can transform the immunosuppressive properties of MDSC and CAF and could be used in combination with PD-1/PD-L1 immune-checkpoint blockade therapy.

AB - To improve current cancer immunotherapies, strategies to modulate various immunosuppressive cells including myeloid derived suppressor cells (MDSC) which were shown to be negative factors in immune-checkpoint blockade therapy, need to be developed. In the present study, we evaluated the role of the local renin-angiotensin system (RAS) in the tumor immune-microenvironment using murine models bearing tumor cell lines in which RAS was not involved in their proliferation and angiogenetic ability. Giving angiotensin II receptor blockers (ARB) to C57BL/6 mice bearing murine colon cancer cell line MC38 resulted in significant enhancement of tumor antigen gp70 specific T cells. ARB administration did not change the numbers of CD11b+ myeloid cells in tumors, but significantly reduced their T-cell inhibitory ability along with decreased production of various immunosuppressive factors including interleukin (IL)-6, IL-10, vascular endothelial growth factor (VEGF), and arginase by CD11b+ cells in tumors. ARB also decreased expression of immunosuppressive factors such as chemokine ligand 12 and nitric oxide synthase 2 in cancer-associated fibroblasts (CAF). Last, combination of ARB and anti-programmed death-ligand 1 (PD-L1) antibodies resulted in significant augmentation of anti-tumor effects in a CD8+ T cell-dependent way. These results showed that RAS is involved in the generation of an immunosuppressive tumor microenvironment caused by myeloid cells and fibroblasts, other than the previously shown proliferative and angiogenetic properties of cancer cells and macrophages, and that ARB can transform the immunosuppressive properties of MDSC and CAF and could be used in combination with PD-1/PD-L1 immune-checkpoint blockade therapy.

KW - angiotensin receptor antagonist

KW - cancer-associated fibroblast

KW - myeloid cell

KW - programmed cell death 1 receptor

KW - renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=85040680334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040680334&partnerID=8YFLogxK

U2 - 10.1111/cas.13423

DO - 10.1111/cas.13423

M3 - Article

C2 - 29034589

AN - SCOPUS:85040680334

VL - 109

SP - 54

EP - 64

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 1

ER -